Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)Mediastinal Cyst: Cysts of one of the parts of the mediastinum: the superior part, containing the trachea, esophagus, thoracic duct and thymus organs; the inferior middle part, containing the pericardium; the inferior anterior part containing some lymph nodes; and the inferior posterior part, containing the thoracic duct and esophagus.Lung Neoplasms: Tumors or cancer of the LUNG.Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)Esophageal Cyst: Any fluid-filled closed cavity or sac (CYSTS) that is lined by an EPITHELIUM and found in the ESOPHAGUS region.Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.Bronchial Neoplasms: Tumors or cancer of the BRONCHI.Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)Bronchopulmonary Sequestration: A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung.Pneumonectomy: The excision of lung tissue including partial or total lung lobectomy.Tomography, X-Ray Computed: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.Radiography, Thoracic: X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.Bronchoscopy: Endoscopic examination, therapy or surgery of the bronchi.Diverticulum, Esophageal: Saccular protrusion beyond the wall of the ESOPHAGUS.Hormones, Ectopic: Hormones released from neoplasms or from other cells that are not the usual sources of hormones.Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Thoracoscopy: Endoscopic examination, therapy or surgery of the pleural cavity.Thoracotomy: Surgical incision into the chest wall.Mediastinoscopy: Endoscopic examination, therapy or surgery of the anterior superior mediastinum of the thorax.Osteoarthropathy, Secondary Hypertrophic: Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed)Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)Carcinoma, Large Cell: A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)Bronchi: The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.Pulmonary Surgical Procedures: Surgery performed on the lung.Atrial Septum: The thin membrane-like muscular structure separating the right and the left upper chambers (HEART ATRIA) of a heart.Empyema: Presence of pus in a hollow organ or body cavity.Tracheal NeoplasmsInappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.Liver Neoplasms: Tumors or cancer of the LIVER.Diagnostic Techniques, Surgical: Methods and procedures for the diagnosis of disease or dysfunction by examination of the pathological site or operative field during surgical intervention.Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)Paraneoplastic Endocrine Syndromes: Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone (HORMONES, ECTOPIC) secretion.Fatal Outcome: Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.Neoplasm Staging: Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.Lung Diseases: Pathological processes involving any part of the LUNG.Retroperitoneal Space: An area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space.Immunoradiometric Assay: Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured.Immunohistochemistry: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.Bronchogenic Cyst: A usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea. It is generally found in the mediastinum or lung and is usually asymptomatic unless it becomes infected.Thoracic Surgery, Video-Assisted: Endoscopic surgery of the pleural cavity performed with visualization via video transmission.Mediastinum: A membrane in the midline of the THORAX of mammals. It separates the lungs between the STERNUM in front and the VERTEBRAL COLUMN behind. It also surrounds the HEART, TRACHEA, ESOPHAGUS, THYMUS, and LYMPH NODES.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Carcinoma, Intraductal, Noninfiltrating: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.Carcinoma, Adenoid Cystic: Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)Receptors, Progesterone: Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.Receptors, Estrogen: Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.Cytosol: Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.

Bronchial carcinoma in patients with pre-existing unilateral lung disease. (1/348)

Forty-six cases of primary bronchogenic carcinoma occurring in patients with other unilateral pleuropulmonary diseases were studied. In 37 cases (80-4%) carcinoma developed in the previously healthy lung. All but one squamous-cell carcinoma and all of five undifferentiated small-cell carcinomas developed in the previously healthy lung while 7 of 15 adenocarcinomas were in the lung with impaired ventilation. It is suggested that the bronchial epithelium of the healthy lung is more exposed to exogenous carcinogens than that of the diseased, underventilated lung, resulting in a higher risk of development of squamous-cell and undifferentiated small-cell carcinoma.  (+info)

Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. (2/348)

Using 12 microsatellite markers, we have studied DNAs from the bronchial lavage of 90 individuals who were referred to an early-lung-cancer clinic in the Northwest of England with suspected lung cancer. Genetic alterations were detected in 15 (35%) of 43 patients with lung cancer but also in 11 (23%) of 47 patients with no cytological or radiological evidence of bronchial neoplasia. No significant differences were found between the referring symptoms in any of the second group of individuals with and without genetic alterations. No correlation was found between smoking exposure and loss of heterozygosity (LOH)/microsatellite alterations (MAs) in the microsatellite markers. On comparing LOH with MAs based on cytology review, we found that the prevalent type of alteration in specimens with cytological evidence of malignancy was LOH; in contrast, the individuals with no cytological evidence of malignancy showed a preponderance of MAs (P = 0.01). Our results indicate that a substantial proportion of cells in the bronchial lavage from suspected lung cancer patients carry identifiable genetic alterations. However, the presence of genetic alterations in the bronchial lavage of individuals with no clinical evidence of lung cancer raises the question whether instability is a phenomenon solely associated with cancer or represents a feature of nonneoplastic diseases. Our results suggest that microsatellite PCR-based assays can be developed as tools for the earlier identification of genetic changes in cells exfoliating in the bronchus.  (+info)

Pulmonary malignancies in the immunocompromised patient. (3/348)

Clinicians should be familiar with immunodeficiency-related malignancies, as their incidence is expected to increase further with the rise in the number and survival of immunocompromised patients. The most common malignancies affecting the lungs in those patients are Kaposi's sarcoma, non-Hodgkin's lymphoma and, to a far less extent, Hodgkin's disease and bronchogenic carcinoma. However, their relative frequency depends on the types of immune deficiency, including those due to congenital disorders, AIDS and drug treatments. This review will summarize epidemiological data on the frequency of immmunodeficiency-related malignancies, recent advances on their pathogenesis and current approaches to their diagnosis and treatment in the various immunosuppressed groups.  (+info)

Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. (4/348)

The proportion of elderly patients presenting with bronchogenic carcinoma is increasing. To study the impact of age on clinical presentation, management and outcome of patients, the authors have reviewed their clinical experience over the last 20 yrs. Between 1977 and 1996, 1,079 patients underwent thoracotomy for primary lung carcinoma in the authors' institution. Patients were grouped by age at the time of surgery as <60 yrs, 60-69 yrs and > or =70 yrs. Although the mode of clinical presentation was similar between all age groups, patients <60 yrs were more prone to have advanced stage carcinoma at the time of diagnosis. The rates of exploratory thoracotomy and pneumonectomy were higher in patients <70 yrs, whereas lobectomies and lesser resections largely predominated in patients > or =70 yrs. The mortality rate following lobectomy and lesser resection increased from 1.3% in patients <60 yrs to 5.5% in patients > or =60 yrs (p=0.04) and the mortality rate following pneumonectomy increased from 6.5% in patients <60 yrs to 13.7% in patients > or =70 yrs (p=0.24). The specific long-term survival, which included only the patients who died from primary lung carcinoma, was similar in all age groups. Operative mortality and survival rates are acceptable in patients > or =70 yrs. Therefore, age in itself should not constitute a contraindication to surgical lung resection for primary lung carcinoma as long as a careful preoperative assessment is performed to appropriately select surgical candidates.  (+info)

Clinical correlation of hepatic flow studies. (5/348)

In 100 consecutive hepatic flow studies, 84 were read as negative. Of these, 73 (87%) also had negative static images. Knowing the nature of the primary tumor did not definitively aid in predicting whether hepatic meastases would have detectable early flow. Five cases showed early flow without defects seen in the static images. Three of these were probably related to lymphomas or allied disorders with altered flow. Two cases were in individuals with gastric carcinoma who had abdoninal radiation. One extrahepatic tumor was detected in the series.  (+info)

Psoriatic arthritis complicating lung cancer. (6/348)

Psoriatic arthritis is an inflammatory arthritis associated with psoriasis. While an elevated incidence of lung cancer has been observed in patients with RA or psoriasis, there has been no report of psoriatic arthritis associated with lung cancer. We here report the first case of psoriatic arthritis which developed lung cancer. In this case, it was suspected that a combination of cigarette smoking, pulmonary fibrosis, and low-dose methotrexate therapy might have promoted the development of lung cancer.  (+info)

Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma. (7/348)

Normal bronchial epithelial cells (NBECs) are at risk for damage from inhaled and endogenous oxidative species and from epoxide metabolites of inhaled polycyclic aromatic hydrocarbons. Epidemiological and in vitro data suggest that interindividual variation in this risk may result from variation in NBEC expression of enzymes that inactivate reactive species by conjugating them to glutathione. Quantitative competitive reverse transcription-PCR was used to measure mRNA levels of glutathione transferases (GSTs) and glutathione peroxidases (GSHPxs) in primary NBECs from subjects with or without bronchogenic carcinoma. Mean expression levels (mRNA/10(3) beta-actin mRNA) in NBECs from 23 subjects without bronchogenic carcinoma compared to those from 11 subjects with bronchogenic carcinoma respectively (in parentheses) were: mGST (26.0, 6.11), GSTM3 (0.29, 0.09), combined GSTM1,2,4,5 (0.98, 0.60), GSTT1 (0.84, 0.76), GSTP1 (287, 110), GSHPx (140, 62.1), and GSHPxA (0.43, 0.34). Levels of GSTP1, GSTM3, and GSHPx were significantly (P < 0.05) lower in NBECs from subjects with bronchogenic carcinoma. Further, the gene expression index formed by multiplying the values for mGST x GSTM3 x GSHPx x GSHPxA x GSTP1 had a sensitivity (90%) and specificity (76%) for detecting NBECs from bronchogenic carcinoma subjects that was better than any individual gene. In cultured NBECs derived from eight individuals without bronchogenic carcinoma and incubated under identical conditions such that environmental effects were minimized, the mean level of expression and degree of interindividual variation for each gene evaluated was less than that observed in primary NBECs. Data from these studies support the hypotheses that (a) interindividual variation in risk for bronchogenic carcinoma results in part from interindividual variation in NBEC expression of antioxidant genes; (b) gene expression indices will better identify individuals at risk for bronchogenic carcinoma than individual gene expression values; and (c) both hereditary and environmental exposures contribute to the level of and interindividual variation in gene expression observed in primary NBECs. Many epidemiological studies have been designed to evaluate risk associated with polymorphisms or gene expression levels of putative susceptibility genes based on measurements in surrogate tissues, such as peripheral blood lymphocytes. Based on data presented here, it will be important to include the assessment of NBECs in future studies. Measurement of antioxidant gene expression in NBECs may identify the 5-10% of individuals at risk for bronchogenic carcinoma. Bronchoscopic sampling of NBECs from smokers and ex-smokers then will allow susceptible individuals to be entered into surveillance and/or chemoprevention studies.  (+info)

Four decades of surgery for bronchogenic carcinoma in one centre. (8/348)

Since the authors' initial experience in the surgical management of bronchogenic carcinoma in 1956, more than 40 years have passed. The purpose of this report was to review the authors' data and compare the results by decade (1956-1966; 1967-1976; 1977-1986; and 1987-1996) in order to assess the changing patterns in bronchogenic carcinoma. A total of 1,597 thoracotomies have been performed. Between the first and last decades of the study, patients' mean age increased from 57 to 63 yrs, the ratio of males to females decreased from 19:1 to 3:1 and the proportion of adenocarcinoma cases increased from 10 to 34%. The operative mortality decreased from 10% in 1967- 1976 to 4% in 1987-1996 and the overall 5-yr survival improved from 27 to 36% during the same period. The rate of lobectomy progressively increased from 32% in 1956-1966 to 61% in 1987-1996, whereas that of pneumonectomy and exploratory thoracotomy decreased from 42 to 28% and from 20 to 4%, respectively. Changing patterns of patient characteristics, histology and type of surgery were associated with a constant improvement in the overall 5-yr survival. This improvement was particularly evident among patients with advanced-stage carcinoma.  (+info)

*Progressive massive fibrosis

PMF can be mistaken for bronchogenic carcinoma and vice versa. PMF lesions tend to grow very slowly, so any rapid changes in ...

*Gilbert Wheeler Beebe

Bronchogenic carcinoma: factors in survival. Linkage of Wartime Military and Veterans' Records in Cancer Research. Record ... Higgins, G. A., & Beebe, G. W. (1967). Bronchogenic carcinoma: factors in survival. Archives of Surgery. 94(4): 539-549. Beebe ...

*Pancoast tumor

synd/2953 at Who Named It? Paulson DL, Shaw RR (May 1960). "Results of bronchoplastic procedures for bronchogenic carcinoma". ... non-small cell lung carcinoma, right lung), from a 47-year-old female smoker. ...

*Timeline of lung cancer

1977). "Intensive chemotherapy of small cell bronchogenic carcinoma". Cancer Treat Rep. 61: 349-54. PMID 194691. CS1 maint: ...

*Lung cancer

1977). "Intensive chemotherapy of small cell bronchogenic carcinoma". Cancer Treatment Reports. 61 (3): 349-354. PMID 194691. ... such as adenosquamous carcinoma. Rare subtypes include carcinoid tumors, bronchial gland carcinomas and sarcomatoid carcinomas ... Lung cancers are carcinomas-malignancies that arise from epithelial cells. Lung carcinomas are categorized by the size and ... The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are ...

*Pulmonary cyst

... may refer to: Bronchogenic cyst Lymphangioleiomyomatosis Pulmonary cyst may be relevant to: Carcinoma Infantile ... "Lung Cyst Caused by Centrally Located Bronchogenic Carcinoma". Arch Bronconeumol. 48 (3): 99-101. doi:10.1016/j.arbres.2011.06. ... Goswamy J, de Kruijf S, Humphrey G, Rothera MP, Bruce IA (2011). "Bronchogenic cysts as a cause of infantile stridor: case ...

*Rak pluća - Википедија, слободна енциклопедија

1977). „Intensive chemotherapy of small cell bronchogenic carcinoma". Cancer Treatment Reports. 61 (3): 349-354. PMID 194691.. ... Edwards, AT (1946). „Carcinoma of the Bronchus". Thorax. 1 (1): 1-25. PMC 1018207 . PMID 20986395. doi:10.1136/thx.1.1.1.. ... 2006). „Bronchioloalveolar carcinoma: a review". Clinical Lung Cancer. 7 (5): 313-322. PMID 16640802. doi:10.3816/CLC.2006.n. ... Većina tipova plućnih kancera su plućni karcinomi malih-ćelija (engl. small-cell lung carcinoma, SCLC). Najčešći simptomi su ...

*Carcinosis

Ruffini, E (2002). "The significance of intraoperative pleural effusion during surgery for bronchogenic carcinoma". European ... Ovarian carcinomas are common. Fluid produced by the cells can produce ascites which is typical in carcinomatosis, but less ... Fluid can be serous as seen in primary peritoneal carcinoma or mucinous such as found in pseudomyxoma peritonei which is ...

*Hyperprolactinaemia

Other causes include chronic renal failure, hypothyroidism, bronchogenic carcinoma and sarcoidosis. Some women with polycystic ...

*Zopiclone

"Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma". Journal of Forensic Science. 46 (5): 1247-1249. ...

*Rak pluća

1977). "Intensive chemotherapy of small cell bronchogenic carcinoma". Cancer Treatment Reports 61 (3): 349-354. PMID 194691. ... Većina tipova plućnih kancera su plućni karcinomi malih-ćelija (engl. small-cell lung carcinoma, SCLC). Najčešći simptomi su ... Raz, DJ; He B, Rosell R, Jablons DM (March 2006). "Bronchioloalveolar carcinoma: a review". Clinical Lung Cancer 7 (5): 313-322 ... November 1968). "Results of resection for oat-cell carcinoma of the lung". Lancet (Elsevier) 2 (7575): 925-927. PMID 4176258. ...

*Evarts Ambrose Graham

5 Wynder EL, Graham EA: Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma: a study of 684 proven cases. ... 6 Announcement of the award of the Lister Medal - Nature 148, 500-500 (25 October 1941). Some Aspects of Bronchogenic Carcinoma ... Some Aspects of Bronchogenic Carcinoma'. His other awards included the gold medal of the Radiological Society of North America ... and William Adams on the first successful removal of a lung for the treatment of bronchogenic carcinoma in 1933. The patient ...

*Pulmonary sequestration

Diseases such as bronchiectasis, tuberculosis, aspergillosis, bronchial carcinoid and bronchogenic squamous cell carcinoma. ...

*Fetal adenocarcinoma

June 1996). "p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas". Hum. Pathol. 27 (6): 542-6. doi: ... A case of combined small cell lung carcinoma featuring components of FA and cells resembling those from carcinoid tumor has ... November 2008). "[Clinicopathologic study of pulmonary adenocarcinoma with features of bronchioloalveolar carcinoma]". Zhonghua ... prognosis of patients with FA as a whole is considered to be better than that of most other forms of non-small cell carcinoma, ...

*Kurt Julius Isselbacher

Isselbacher, KJ; Klaus, H; Hardy, HL (November 1955). "Asbestosis and Bronchogenic Carcinoma, Report of One Autopsied Case and ...

*David A. Karnofsky

The Use of the Nitrogen Mustards in the Palliative Treatment of Carcinoma - with Particular Reference to Bronchogenic Carcinoma ...

*Performance status

The Use of the Nitrogen Mustards in the Palliative Treatment of Carcinoma - with Particular Reference to Bronchogenic Carcinoma ...

*Richard Bayliss

Bayliss was awarded his MD in 1946, his thesis being on the subject of cardiac metastases from bronchogenic carcinoma. He ...

*Tumor-like disorders of the lung pleura

However, studies have demonstrated that pleural plaques are an independent risk factor for developing bronchogenic carcinoma ...

*1950 Wynder and Graham Study

Thus, researchers concluded that smoking is responsible for the onset of bronchogenic carcinoma, but did not establish a causal ... This study was a retrospective, case-control study that compared smoking habits of 684 individuals with bronchogenic carcinoma ... of men with bronchogenic carcinoma were heavy to chain smokers, compared to 73.7% of the general population. Statistically, it ... those with bronchogenic carcinoma, and controls, those without the condition. There were 605 microscopic confirmations of the ...

*Edelfosine

A phase II trial on the effect of Edelfosine on advanced non-small-cell bronchogenic carcinoma had a "remarkable" "high ... in Advanced Non-Small-Cell Bronchogenic Carcinoma". Onkologie. 15: 375-382. doi:10.1159/000217391. Houlihan, WJ; Lohmeyer M; ... Among them a phase I trials with solid tumors or leukemias and phase II with non-small-cell lung carcinomas (NSCLC). In a Phase ... Shafer, SH; Williams CL (2003). "Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to ...

*CEBPG

... with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma ...

*Nail clubbing

... a search for signs of bronchogenic carcinoma (or other causes of clubbing) might be indicated. A congenital form is also known ...

*Superior vena cava syndrome

... such as bronchogenic carcinoma including small cell and non-small cell lung carcinoma, Burkitt's lymphoma, lymphoblastic ... most commonly bronchogenic carcinoma, typically a tumor outside the vessel compressing the vessel wall. It can also be caused ...

*Giant-cell carcinoma of the lung

3.0.co;2-8. Patton MM, McDonald JR, Moersch HJ (1951). "Bronchogenic large cell carcinoma". J Thorac Cardiovasc Surg. 22: 88. ... Small-cell carcinoma Squamous cell carcinoma Adenocarcinoma Large-cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... Giant-cell carcinoma of the lung (GCCL) is a rare histological form of large-cell lung carcinoma, a subtype of undifferentiated ... Only small-cell carcinoma and large-cell carcinoma had shorter average survival.) Most GCCL have already grown and invaded ...

*Chlormethine

... and bronchogenic carcinoma Mechlorethamine is often administered intravenously, but when compounded into a topical formulation ...

*List of diseases (B)

Basal cell carcinoma. *Basal cell nevus anodontia abnormal bone mineralization. *Basal ganglia diseases ... Bronchogenic cyst. *Bronchopulmonary amyloidosis. *Bronchopulmonary dysplasia. *Brown syndrome. *Brown-Séquard syndrome. Bru[ ...

*Timeline of United States history (1950-69)

1967 - Jack Ruby died of a pulmonary embolism, secondary to bronchogenic carcinoma (lung cancer), on January 3, 1967 at ...
We investigated the role of interleukin 8 (IL-8) in mediating angiogenesis in human bronchogenic carcinoma. Increased quantities of IL-8 were detected in tumor tissue as compared with normal lung tissue. Immunohistochemical staining of tumors revealed primary localization of IL-8 to individual tumor cells and demonstrated the capacity of tumor to elaborate IL-8. Functional studies that used tissue homogenates of tumors demonstrated the induction of both in vitro endothelial cell chemotaxis and in vivo corneal neovascularization. It is important to note that the addition of neutralizing antisera to IL-8 to these assays resulted in the marked and specific attenuation of these responses. Our observations definitively establish IL-8 as a primary mediator of angiogenesis in bronchogenic carcinoma and offer a potential target for immunotherapies against solid malignancies. ...
A patient is described with small cell carcinoma of the lung, associated with profound hypophosphataemia and hyponatraemia. Increased phosphate excretion and inappropriately high urine osmolality were observed. The abnormalities are consistent with tumoral hypophosphataemia and inappropriate antidiuresis. These tumour-related metabolic abnormalities have only been described once before with this malignancy.. ...
This is often referred to as bronchogenic carcinoma. It is recognized as being one of the most common complications of asbestos exposure and it invariably causes death. Asbestos induced carcinoma of the lung is one of the most fatal of the common cancers.. 80% of all people who contract bronchogenic carcinoma die within two years of diagnosis being made. It is not necessary for a worker to have asbestosis in order to attribute bronchogenic carcinoma to asbestos exposure. The attribution can be made if there has been sufficient exposure to asbestos dust.. Pleural Mesothelioma ...
Right lung upper lobe apical segment bronchogenic cancer with pleural invasion as well as malignant mediastinal and right hilar metastatic lymphadenopathy and right pleural effusion.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account ...
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: A cancer and leukemia group B study. Journal of Clinical Oncology. 1983 ...
Summary: This review focuses on the cavitary lesions that are encountered in oncology patients, including primary bronchogenic carcinoma, pulmonary metastas...
Tracheobronchial foreign body (TFB) aspiration is a common occurrence in children compared with adults. Long-standing cases of TFB aspiration during childhood presenting in an adult have rarely been reported. We report the unique case of an endobronchial Playmobil traffic cone that went undetected for 40 years and presented as a suspected bronchogenic carcinoma. This was subsequently removed successfully with flexible bronchoscopy. To our knowledge this is the first case of a TFB that was overlooked this length of time. ...
Background & objective: The histologic distinction of small cell from non-small cell lung carcinoma and correct identification of all subtypes of lung carcinoma are very important in treatment management. The main method for histologic classification of lung tumors is based on morphology. However, in small bronchoscopic biopsies in particular, distinction is very difficult upon morphology alone. The current study aimed at evaluating the utility of a panel of antibodies, consisting of thyroid transcription factor (TTF-1), P63, high molecular weight keratin [HMWK (34βE12)], cytokeratin (CK7), and cluster of differentiation (CD56) for accurate distinction of bronchogenic carcinomas. Methods: Bronchoscopic biopsies of 60 lung carcinoma cases including 20 small cell carcinomas, 20 adenocarcinomas, and 20 squamous cell carcinomas (SCCs) with typical morphologic features were selected. All these cases were immunohistochemically stained for TTF-1, P63, HMWK (34βE12), CK7, and CD56. All immunostained slides
Although the lung is not usually considered a major target organ of sex hormones, epidemiological observations, studies of pulmonary neoplasms in laboratory animals, and investigations of carcinomas derived from other "nontarget" organs suggest that sex hormones may have a role in the pathogenesis of bronchogenic carcinoma. To confirm that estrogen (ER) and progesterone receptors are present in human lung cancers, 19 resected lung cancers were examined for receptors using a prelabeled sucrose gradient method. Three squamous cell carcinomas were positive for ER (,6.9 fmol/mg cytosol protein). Three squamous cell carcinomas, two adenocarcinomas, and one small cell carcinoma were positive for progesterone receptors (,6.9 fmol/mg cytosol protein). One tumor, a squamous cell carcinoma arising in a woman who smoked, had an ER level of 301 fmol/mg, a highly positive level even for breast cancers. These observations may provide a basis for adjuvant hormonal therapy in selected lung cancer ...
The proportion of elderly patients presenting with bronchogenic carcinoma is increasing. To study the impact of age on clinical presentation, management and outcome of patients, the authors have reviewed their clinical experience over the last 20 yrs. Between 1977 and 1996, 1,079 patients underwent thoracotomy for primary lung carcinoma in the authors institution. Patients were grouped by age at the time of surgery as ,60 yrs, 60-69 yrs and , or =70 yrs. Although the mode of clinical presentation was similar between all age groups, patients ,60 yrs were more prone to have advanced stage carcinoma at the time of diagnosis. The rates of exploratory thoracotomy and pneumonectomy were higher in patients ,70 yrs, whereas lobectomies and lesser resections largely predominated in patients , or =70 yrs. The mortality rate following lobectomy and lesser resection increased from 1.3% in patients ,60 yrs to 5.5% in patients , or =60 yrs (p=0.04) and the mortality rate following pneumonectomy increased ...
Despite extensive research, the role of the commonly employed tumour markers in the diagnosis of lung carcinoma is yet to be clarified. The utility of a new marker, CYFRA 21-1, in the preoperative evaluation of patients with bronchogenic carcinoma was investigated. CYFRA 21-1 was determined with a radiometric assay in serum of 280 patients with lung cancer and 208 patients with various nonmalignant lung diseases. The levels of the marker were significantly higher in lung cancer patients. Among benign lung diseases, elevated CYFRA 21-1 levels were found in pulmonary fibrosis. Using a cut-off of 3.2 ng.ml-1 (95th percentile of levels obtained in benign lung disease), the total sensitivity of the marker was 48%. The best sensitivity was obtained in squamous cell lung cancer (60%). The highest values of CYFRA 21-1 were found in metastatic lung cancer, and the marker sensitivity was more elevated in stage IIIb and IV. On the other hand, 40% of patients with surgically resectable lung cancer had CYFRA ...
There was no mortality, serious complications or transfusion.. Conclusion. Mediastinoscopy allows accurate information from biopsies of lymph nodes. In our series, the majority (68.2%) showed non-malignant granulomatous diseases, predominantly TB 29.5%, sarcoidosis 14.8%, and concurrent sarcoidosis and TB 12.5%. In the West, 83% are diagnosed with malignancy, of which 81% have lung cancer.2 TB is now uncommon in the West. Pakistan ranks 6th in the estimated global TB burden list, with an incidence of 181/100000, and prevalence 359/100000.4. Sarcoidosis is a diagnostic challenge in countries where TB is endemic.5 The estimated prevalence of sarcoidosis in this series was 27%, which seems higher than the West (12%).2 A series from India reports 18%.1 In our study, the prevalence of bronchogenic carcinoma was 24% and lymphoma 4.5%. Eight (33.3%) of these had N0 and N1 disease and underwent resection of the primary tumours. Thirteen (61.9%) were diagnosed with N2 or N3 disease and were spared a ...
Belongs to a class of drugs known as alkylating agents; it slows or stops the growth of cancer cells in the body. To be more effective it is sometimes used in combination with other chemotherapy medications. Used to treat lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian carcinoma, retinoblastoma, breast cancer, Ewings sarcoma, bronchogenic carcinoma, small cell lung carcinoma, and other types of cancer. Also known as Cytoxan.
SCLC accounts for approximately 15% of bronchogenic carcinomas. At the time of diagnosis, approximately 30% of patients with SCLC will have tumors confined to the hemithorax of origin, the mediastinum, or the supraclavicular lymph nodes. These patients are designated as having limited-stage disease (LD).[1] Patients...
A patient with watery diarrhea syndrome secondary to bronchogenic carcinoma responded to treatment with clonidine and lidamidine. Stool weight decreased to 43% and 53% of control on two separate trials of clonidine. Stool weight decreased to 35% of control during a trial of lidamidine. Both clonidine and lidamidine increased sodium and chloride absorption in vitro in human intestine. Clonidine, lidamidine, or drugs that are structurally similar may become therapeutic choices for secretory diarrhea. ...
Introduction Overall, colorectal cancer ranks second only to bronchogenic carcinoma among the cancer killers. Adenocarcinomas constitute the vast majority of colorectal cancers and represent 70% of all malignancies arising in the gastrointestinal tract.
A 32 year old female life long non-smoker with a history of mild asthma, previously well ... Bronchogenic carcinoma D) Atelectasis E) Lung abcess
SIADH. Alexander Usorov, MD July 31, 2007. SIADH. Most frequent cause of hyponatremia First described by Schwartz et al in 1957 in 2 pts with bronchogenic carcinoma Arginine vasopressin was then identified. ADH. Synthesized in hypothalamus Transported down to posterior pituitary...
Characteristics of the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery II (GCCB-S-II) and global description of their ...
We offer clinical cancer updates, treatment guidance, and research news to the oncology nursing community. Visit us often for drug therapy testing results, patient care information and more. Download our FREE app today.
Eloise Mikkonen from the University of Tampere, Finland, is part of a collaborative project investigating a connection between herpes simplex virus and Alzheimers disease. Thanks to a Travelling Fellowship from DMM, she visited her collaborators in Umeå University, Sweden, and the team have now published their work in DMM. Read more on her story here.. Where could your research take you? The deadline to apply for the current round of Travelling Fellowships is 23 February 2018. Apply now!. Did you know that DMM also offers conference travel grants? Apply by 9 March 2018. Find out more here.. ...
SCLC represents approximately 15% to 20% of all bronchogenic malignancies and is biologically and clinically distinct from non-small cell types. Despite a good initial response to chemotherapy, most SCLC patients ultimately develop resistance and relapse. Because available therapies have little effect on survival, new therapeutic approaches are needed (28, 29). Epigenetic changes, such as DNA methylation and histone acetylation, have a central role in the control of gene transcription and are early events in lung tumorigenesis (1, 26, 30, 31). 5-AZA-dC and HDAC inhibitors can reactivate aberrantly hypermethylated or acetylated genes, thereby inhibiting tumor cells by inducing apoptosis, cell cycle arrest, and differentiation (32-35). In addition to its demethylating function, 5-AZA-dC may also play an antineoplastic role that is methylation independent (36, 37).. HDAC inhibitors alone inhibited growth in four of nine SCLC cell lines, whereas 5-AZA-dC alone inhibited growth in two cell lines ...
BBB Accredited since 2010. This business provides Pet Supplies & Foods - Retail in Cedarburg, WI. View rating, customer reviews, contact information and more.
Thirty-two patients with inappropriate secretion of antidiuretic hormone (ADH) complicating small-cell carcinoma of the bronchus were identified from a total of 226 patients with small-cell carcinoma of the bronchus treated at the Christie Hospital, Manchester, between 1978 and 1984. Basic data were collected from patients files concerning the extent of the tumour, symptoms of inappopriate secretion of antidiuretic hormone, biochemical findings, treatment, the course of the inappropriate secretion of ADH and that of the underlying tumour. The data were then analysed and compared with results of previous studies. The response of the inappropriate secretion of ADH to treatment was found to be a significant prognostic factor. Further data were collected to determine the reason for this but it was difficult to drawn any firm conclusions. ...
Looking for online definition of bronchogenic cancer in the Medical Dictionary? bronchogenic cancer explanation free. What is bronchogenic cancer? Meaning of bronchogenic cancer medical term. What does bronchogenic cancer mean?
Definitive histology of the specimen was infiltrating colloid adenocarcinoma with immunophenotype of enteric adenocarcinoma arising from a benign cystic mucoid lesion compatible with bronchogenic cyst. Immunohistochemical staining was positive for cytokinin 20 and CDX 2, and negative for cytokinin 20 and TTF1. Mediastinal lymph nodes were not affected.. The final diagnosis was enteric adenocarcinoma arising from a bronchogenic cyst. No additional lesions were found on colonoscopy and further abdominal exams. Because no signs of disease dissemination were found, no additional therapy was applied. The patient is alive without recurrence of disease 6 months after the surgery.. Bronchogenic cysts are congenital lesions thought to originate from the primitive ventral foregut,2 and are the result of abnormal budding that "pinches off" from the tracheal tree in the stage when bronchial buds develop into the primitive of respiratory tree.9,10 Bronchogenic cysts are relatively rare, with a prevalence of ...
TY - JOUR. T1 - Supradiaphragmatic bronchogenic cyst extending into the retroperitoneum. AU - Jo, Won-Min. AU - Shin, Jae Seung. AU - Lee, In Sung. PY - 2006/1/1. Y1 - 2006/1/1. N2 - We experienced a case of bronchogenic cyst located on the left lower pleural space extending into the retroperitoneum in a 33-year-old man with left chest pain. Preoperative imaging studies and operative findings showed a broad-based cystic mass on the left lower posterior pleura and diaphragmatic pleura extending into the retroperitoneal region across the diaphragm. Histologic studies proved this mass to be a bronchogenic cyst.. AB - We experienced a case of bronchogenic cyst located on the left lower pleural space extending into the retroperitoneum in a 33-year-old man with left chest pain. Preoperative imaging studies and operative findings showed a broad-based cystic mass on the left lower posterior pleura and diaphragmatic pleura extending into the retroperitoneal region across the diaphragm. Histologic studies ...
Do You Have Bronchogenic Cyst? Join friendly people sharing true stories in the I Have Bronchogenic Cyst group. Find support forums, advice and chat with groups who share this life experience. A Bronchogenic Cyst anonymous support group with informat...
Pancoast tumour, otherwise known as superior sulcus tumour, refers to a relatively uncommon situation where a primary bronchogenic carcinoma arises in the lung apex at the superior pulmonary sulcus and invades the surrounding soft tissues. Termi...
Bronchogenic cysts are small, solitary cysts or sinuses, most typically located in the region of the suprasternal notch or over the manubrium. Bronchogenic cysts are formed in the 6th week of gestation from an abnormal budding of the tracheal diverticulum. They are lined by respiratory type (ciliated) epithelium, which is characterized by cilia. Histologically these are also composed of cartilage, smooth muscle, fibrous tissue and mucous glands. These cysts originate from the ventral foregut that forms the respiratory system. These cysts are located close to the trachea or main stem bronchi. Rarely there is communication of the cyst with the tracheobronchial tree. These cysts are found most often in young adults and are rare in infancy. The usual symptoms are the result of compression by the cyst, e.g., difficulty breathing or swallowing, cough, and chest pain. Malignant degeneration has been reported in these cysts on rare occasions. Chest x-rays show a smooth density just in front of the ...
Mediastinal bronchogenic cysts are encountered relatively often, but in many cases, diagnosis using imaging modalities, is difficult. Early surgical excision of bronchogenic cysts is recommended as a...
Thirty-two patients who presented with haemoptysis and in whom a chest radiograph showed no suggestion of a tumour are reviewed. Six had bronchogenic carcinoma diagnosed� by bronchoscopy and I had an adenoid cystic tumour of the trachea.
Trade Name: Mustargen®. How is this drug used? Mechlorethamine is FDA approved for the treatment of advanced Hodgkins disease, lymphosarcoma, chronic myelocytic or chronic lymphocytic leukemia, polycythemia vera, mycosis fungoides, bronchogenic carcinoma, and metastatic cancer resulting in effusion. It is important for patients to remember that physicians have the ability to prescribe medication for conditions other than those for which the drug has been approved by the FDA. Patients who have received a prescription of this drug for a condition other than which it is approved may wish to discuss this issue with their physician.. What is the mechanism of action? Mechlorethamine belongs to a group of drugs called alkylating agents. Alkylating agents produce their anti-cancer effects by causing a chemical reaction that damages the DNA in a cell. The chemical reaction, called interstrand cross-linking, inhibits the cancer cell to grow or replicate and/or ultimately causes cellular death.. How is ...
There is preliminary evidence linking waterpipe use to disease, though this research is made difficult by the fact that many waterpipe users also smoke cigarettes24,27,66 and/or engage in other behaviours that may increase cancer risk.67 Waterpipe use likely increases the risk of bronchogenic carcinoma,68 as well as lung,16,20,69 oral,8 and bladder21,70 cancers. The notion that waterpipe use is associated with cancer is not surprising, given that, like cigarette tobacco, the tobacco used in waterpipes contains tobacco specific nitrosamines,71 and that waterpipe extract produces degeneration and hyperkeratosis in rat mucosa.72 Moreover, in a study comparing 35 healthy waterpipe users with 35 healthy, non-exposed controls, waterpipe use was associated with a significant increase in frequency of chromosomal aberrations and sister chromatid exchanges.63 While the sample size was low, there were obvious trends toward a dose dependent relation on these outcome measures when the data were analysed ...
Photodynamic therapy (PDT) utilizes a combination of sensitizer, visible light and molecular oxygen to generate singlet oxygen and reactive oxygen species (ROS) such as hydrogen peroxide, hydroxyl radical and superoxid anion. Photochemical reactions lead to damage and destruction of cancer cells. The most suitable and effective source of radiation used in PDT is a laser. For this study, a semiconductor laser with output power of 50 mW and 675 nm was selected. In this paper we report a generation of ROS using chloroaluminium disulphonated phthalocyanine (ClAlPcS2) in A549 bronchogenic carcinoma cell line after PDT in vitro. Phthalocyanines, belonging to a new generation of substances for PDT, exhibit effective tissue penetration because of their proper light absorption region, chemical stability and photodynamic stability. The fluorescence measurement with molecular probes, CM-H2DCFDA and Amplex Red, was performed for detection of ROS generation and hydrogen peroxide release from cells. Our ...
A bronchogenic cyst is an inherited condition in which a person has a cyst in the central area of his or her chest cavity, which...
Sep 18, 2018 - Find best Cardiothoracic Surgeons for Bronchogenic Cyst / Mass near you & make an appointment online instantly! Bronchogenic Cyst / Mass appointments are guaranteed and free!
PRIMARY OBJECTIVES:. I. To determine maximally tolerated light dose (MTID). Identify systemic and normal tissue toxicity using 2-[hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) for photodynamic therapy in patients with bronchogenic carcinoma-in-situ (CIS) or microinvasive carcinoma.. SECONDARY OBJECTIVES:. I. To study tumor response in patients with bronchogenic carcinoma-in-situ (CIS) or bronchogenic microinvasive carcinoma.. OUTLINE: This is a dose-escalation study.. Patients receive HPPH intravenously (IV) over 1 hour on day 1. Patients then photodynamic therapy with laser light on day 3. Patients also undergo therapeutic bronchoscopy for endoscopic debridement on day 5.. After completion of study treatment, patients are followed up at 4-6 weeks, 6 months, and then periodically for at least 2 years. ...
Shorthouse, A J.; Smyth, J F.; Peckham, M J.; and Steel, G G., "Comparison of the chemosensitivity of bronchial carcinoma xenografts with donor patients. Abstr." (1980). Subject Strain Bibliography 1980. 1141 ...
The co-incidence of synchronous intraepithelial neoplasia and early stage invasive lung cancer is not a rare phenomenon. The need for curative treatment and the invasive potential of squamous cell pulmonary carcinoma in situ have been a topic of controversy. Surgical resection still remains the treatment of choice. Varieties of endoscopic techniques such as brachytherapy were developed as an alternative to surgery in selected patients. External beam radiation therapy has been used traditionally in combination with endobronchial brachytherapy in the treatment of roentgenographically occult lung cancer, and can be offered for all patients, but is handicapped, because these tumors are radiographically invisible ...
INTRODUCTION. Nonbacterial endocardial vegetations of a specific morphologic and histologic pattern, and not attributable to other diseases, such as rheumatic fever or lupus erythematosus, have been described under various names. The appellations have usually attempted to denote the authors concept of its pathogenesis. The terms "terminal" and "marantic" endocarditis or endocardiosis imply a type of vegetation or valve change that terminates a chronic illness, and that it is a more or less incidental finding of only pathologic interest. There are many examples which do not terminate a long-term illness, such as carcinoma, but which may be seen in more or ...
An 11-month-old boy born of non-consanguineous marriage presented with a cough for 15 days and fever and breathlessness for 3 days. He had similar complaints at the age of 7 months and was hospitalized for same for 10 days and diagnosed as bronchiolitis and treated with IV antibiotics and nebulization. He was again hospitalized at 8 months of age for pneumonia and treated with IV antibiotics for 14 days. At that time, he was ventilated and bronchoalveolar lavage grew Klebsiella pneumoniae. He has had repeated episodes of cough and breathlessness and has been treated with antibiotics and steroids. On examination, the child had severe respiratory distress with decreased air entry on the left side. He was given nebulization, hydrocortisone but continued to develop stridor and difficulty in breathing. The child was then put under ventilator and condition improved. CT chest showed a retrotracheal bronchogenic cyst. The child underwent excision of the bronchogenic cyst and was alright after that ...
Bronchogenic Cyst (Differential Diagnosis as before). metu_16a_n.jpg: 9.6-year-old boy with symptoms of the airways and a round shadow on the right side at the border of the upper mediastinum in the thorax x-ray. The site close to the trachea and bifurcation (clear longitudinal structure) allows - together with the clinical presentation - the suspicion of a malformation cyst of the bronchogenic type. metu_16b_n.jpg and metu_16c_n.jpg: After the division of the mediastinal pleura a cystic structure is recognizable. It lies between the azygos vein and the superior vena cava to the right of the trachea and bifurcation. The diameter is 3 to 4 cm; leaking out masses of mucus that have been causing a slow growth of the cyst, and the close relation to the airways explain the frequent symptoms and signs of the respiratory organs in bronchogenic cysts. metu_16a_n.jpg and metu_16b_n.jpg and metu_16c_n.jpg: In both cases the clinical, radiological and operative suspicion of a bronchogenic cyst was ...
In patients presenting with persistent hoarseness due to left recurrent laryngeal nerve (LRLN) palsy and an abnormal left hilum on chest radiographs, a major cause is bronchogenic carcinoma. We describe two cases presenting with such a combination of symptoms and signs in whom a diagnosis of bronchogenic carcinoma was suspected. In each case, the LRLN palsy was in fact due to direct compression of the nerve by an aortic aneurysm.. ...
Superior vena cava syndrome (SVCS), is a group of symptoms caused by obstruction of the superior vena cava (a short, wide vessel carrying circulating blood into the heart). More than 90% of cases of superior vena cava obstruction (SVCO) are caused by cancer - most commonly bronchogenic carcinoma, typically a tumor outside the vessel compressing the vessel wall. It can also be caused by compression from an aortic aneurism or it can sometimes have a benign cause. Characteristic features are edema (swelling due to excess fluid) of the face and arms and development of swollen collateral veins on the front of the chest wall. Shortness of breath and coughing are quite common symptoms; difficulty swallowing is reported in 11% of cases, headache in 6% and stridor (a high-pitched wheeze) in 4%. The condition is rarely life-threatening, though edema of the epiglottis can make breathing difficult, and edema of the brain can cause reduced alertness, and in less than 5% of cases of SVCO, severe neurological ...
Robert Hyland, MD, FRCPC, Division of Respirology, Department of Medicine, St. Michaels Hospital, University of Toronto, Toronto, ON. Hemoptysis is an important clinical problem that is especially ominous when seen in older patients. The main causes of hemoptysis in first world nations are bronchogenic carcinoma, bronchitis, and bronchiectasis. In older patients cancer remains the main concern, especially if there is a smoking history. The diagnostic approach to nonmassive hemoptysis starts with a chest x-ray, followed by a CT scan and then fibre optic bronchoscopy, which is well tolerated by older adults. In massive hemoptysis, chest x-ray is usually followed immediately by fibre optic or rigid bronchoscopy. Older patients require closer monitoring due to poor cardiopulmonary reserve; management options include endoscopic interventions, bronchial artery embolization ...
Dermatomyositis, Neck Mass, Vocal Cord Paralysis Symptom Checker: Possible causes include Papillary Thyroid Carcinoma, Medullary Thyroid Carcinoma, Bronchogenic Carcinoma. Check the full list of possible causes and conditions now! Talk to our Chatbot to narrow down your search.
Malignant Pericardial Effusion, See Also Autosomal Recessive Sick Sinus Syndrome, Tuberculosis Symptom Checker: Possible causes include Non-Hodgkin Lymphoma, Bronchial Adenocarcinoma, Bronchogenic Carcinoma. Check the full list of possible causes and conditions now! Talk to our Chatbot to narrow down your search.
Bronchogenic mediastinal cysts (BMC) are a rare pathology, accounting for 18% of all primitive mediastinal tumors and represent the most frequent cystic lesions in this anatomic region [1-3].. They represent congenital malformations arising from an abnormal division of the tracheobronchial tree. In relation to the time of separation from the main tracheobronchial tree, the cysts may localize into the lung parenchyma or in the mediastinum, with percentages of 33% and 66%, respectively [4-6].. They are usually unilocular, rarely multilocular. Their wall is represented by a ciliated columnar epithelium lining, cartilage structure and occasionally may contain a mucinoid filling. BMC are usually asymptomatic, and often casually diagnosed. When present, symptoms are usually related to the area of occurrence and include chest pain, cough, dyspnoea, dysphagia, or emoptysis [7, 8].. Complications may occur, including infection, emoptysis, trachea or superior vena cava compression, intracystic ...
Eur J Cardiothorac Surg. 2014 Mar;45(3):527-30. doi: 10.1093/ejcts/ezt436. Epub 2013 Sep 18. Case Reports; Research Support, Non-U.S. Govt
PubMed Central Canada (PMC Canada) provides free access to a stable and permanent online digital archive of full-text, peer-reviewed health and life sciences research publications. It builds on PubMed Central (PMC), the U.S. National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature and is a member of the broader PMC International (PMCI) network of e-repositories.
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
METHODS: All bronchoscopies performed for suspected bronchial carcinoma at Papworth Hospital, Cambridge, United Kingdom, over the last 3 years were reviewed retrospectively. Patients with peribronchial disease, as evidenced by submucosal infiltration or extrinsic compression on bronchoscopy, were selected for TBNA. Patients with computed tomography evidence of subcarinal lymphadenopathy were also included. In total we identified 78 patients: 67 with peribronchial disease and 21 with subcarinal lymphadenopathy. All 78 patients underwent TBNA, and in 8 of these TBNA was performed in 2 sites. ...
Abstract: Bronchogenic cysts are rare congenital lesions of the bronchial tree which are mostly asymptomatic. Rarely when the size is large it can compress on the adjacent structures in the mediastinum. We report a rare case of 10 month old baby presented with recurrent lower respiratory tract infection, was suspected to have a pericardial cyst on echocardiography. On further imaging it was confirmed to be a large bronchogenic cyst from the carina compressing on the left atrium and the left bronchus causing congenital lobar emphysema of the left lung. In view of compression of the adjacent structures patient was sent for surgery. Though congenital bronchogenic cysts involving pericardium and intracardiac tissues have been reported but mediastinal bronchogenic cysts compressing on left bronchus causing congenital lobar emphysema have rarely been reported. Key words: Bronchogenic cyst, Congenital lobar emphysema.. ...
Threeteen patients of lung cancer of center type underwent carinal resections in our department from January 1985 to December 1996. There were 3 patients, T3N2M0 and 10 patients, T4N2M0. Palliative resections were performed for 3 patients and radical resections, for 10 patients. Carinal resection with right pneumonectomy was done in 3 patients, part carinal resection with right pneumonectomy 6 patients, part carinal resection with left pneumonectomy 1 case, and part carinal resection with right sleeve upper and middle lobectomy 3 patients. There were no operative complications and deaths. The 3-year survival rate was 54% and the 5-year survival rates, 30%. One patient has survived for 8 years. The satisfied results of operative therapy were followed when no lymph node metastesis in mediastinum and mass could be resected.
The incidental finding of a pulmonary nodule on computed tomography (CT) is becoming an increasingly frequent event. The discovery of such a nodule should evoke the possibility of a small bronchogenic
The third case of a culturally and histologically proven candidosis of the prostate in the world literature available to us is reported. Autopsy of a 59-year-old man with metastasizing bronchial carcinoma as predisposing primary disease revealed a local candidosis of the prostate in the left lobe of the prostate, without evidence of a Candida sepsis. Parallel and different aspects in comparison with the other two cases are described.
Purpose: To assess various volume based PET quantification metrics including: metabolic tumor volume (MTV) and total lesion glycolysis (TLG) with different thresholds as well as background activity based PET metrics (Background Subtracted Lesion activity (BSL) and Volume (BSV)) as prognostic markers for progression free and overall survival (PFS, OS) in early stage I and II non-small cell lung cancer (NSCLC) after resection. Patients and Methods: 133 patients received an adequate FDG PET/CT scan prior to surgery between January 2003 and December 2010. All PET activity metrics showed a skewed distribution and were log-transformed before calculating the Pearson correlation coefficients (PCC). Survival tree analysis was used to discriminate between high and low risk patients and to select the most important prognostic markers. Akaike information criterion (AIC) was used to compare two uni-variate models. Results: Within the study time 36 patients died from NSCLC and 26 patients from other causes. ...
BACKGROUND: When hormones are detected in the serum of patients with bronchial carcinoma they are generally considered to originate from the tumour, but this may be not the only explanation. Pulmonary endocrine cells proliferate in lungs affected by non-neoplastic disease and their products are often demonstrable in the serum. The aim of this study was to examine the pulmonary endocrine systems of a series of tumour-bearing lungs to see whether any changes in them could possibly account for raised levels of pulmonary peptides in the blood. METHODS: The morphology, number, distribution, and content of pulmonary endocrine cells in 30 pairs of tumour-bearing lungs from patients coming to necropsy with bronchial carcinoma were examined. These features were related to the pathology of the tumour and to other pathological changes present in the lungs, and compared with pulmonary endocrine cells in 10 pairs of control lungs from patients without pulmonary disease. RESULTS: Increased numbers of ...
Aceptado el 31 de agosto de 2010. Abstract. Because the deposited 222Rn progeny distribution in lung airways, these sources can contribute hardly to critical cells absorbed dose in neighbourhood of alpha track by the alpha particles from 218Po and 214Po. According to epidemiological data [1], lung cancers are primarily bronchogenic and mainly originate in the first five airway generations of the bronchial tree. Generally for deposited energy calculations, uniform deposit in source layers and the whole layers as sources has been considerated too. Discretional point deposits in the diferent and most important bronqui (BB) and bronchial (bb) layers for main generations is a more realistic case. Because that facts we have calculated the average deposited energy by Monte Carlo in the most important different target cell layers for the main BB and bb branch generations considering the radioactive 222Rn progeny puntual deposit in the source epithelium walls, from this location, It irradiate the ...
Soft tissue sarcomas (STS) constitute a rare tumour entity comprising over 50 histological subtypes. MicroRNAs (miRNAs) are short non-protein coding RNA molecules that regulate gene expression by targeting the 3-untranslated region of messenger RNAs. They are involved in a variety of human diseases, including malignancies, such as endometrial cancer, osteosarcoma, bronchial carcinoma and breast cancer. In STS, various miRNAs are differentially expressed, thus contributing to development, progression and invasion. Therefore, the aim of the present review is to summarise current knowledge on the role of miRNAs in STS. Furthermore, the potential role of miRNAs as diagnostic, prognostic and predictive biomarkers is discussed.
The differential diagnosis for centrilobular densities generally falls into the category of peribronchiolar disease, but may include perilymphatic or perivascular disease. Centrilobular densities with a "tree-in-bud" appearance are usually due to endo/peribronchiolar diseases and may be seen with bronchopneumonia (particularly in regions peripheral to frank consolidation), bronchiectasis and cystic fibrosis, bronchogenic spread of tuberculosis, bronchiolitis obliterans and bronchiolitis obliterans organizing pneumonia, respiratory bronchiolitis, and hypersensitivity pneumonia [2].. References. 1. Slone R. Differential diagnosis for the chest. In: R Slone, F Gutierrez, A Fisher (eds): Thoracic imaging: a practical approach, New York, 1999, McGraw-Hill, p 38.. 2.Webb W, Müller N, Naidich D. High-resolution CT of the Lung, 2nd ed., Philadelphia, 1996, Lippincott-Raven Publishers, pp 98-103.. ...
A Colour atlas of clinical application of fibreoptic bronchoscopy , A Colour atlas of clinical application of fibreoptic bronchoscopy , کتابخانه دیجیتال جندی شاپور اهواز
Ernst Wynder was one of the outstanding entrepreneurs of modern American medicine. I became involved with him in the mid-1970s, not long after he organized the American Health Foundation, a non-profit research and public health enterprise in New York City. We were first thrown together on the Steering Committee of MRFIT, in which trial he and Peter Peacock and Charles Arnold directed the New York City unit.. Wynders academic credentials dated from a pioneering 1951 publication with surgeon Ewarts Graham in St. Louis, a case-control study of cigarette smoking and death from bronchial carcinoma. They documented what Graham and Ocshner, leading chest surgeons of the day, were observing clinically and preaching to any and all who would listen: squamous-cell carcinoma of the bronchus occurred almost exclusively among heavy cigarette smokers. The Wynder-Graham clinical-epidemiologic demonstration, methodologically advanced for its day, was acknowledged by all in the field but never by any of the ...
Do You Have Carcinoma, Oat Cell? Join friendly people sharing true stories in the I Have Carcinoma, Oat Cell group. Find support forums, advice and chat with groups who share this life experience. Carcinoma, Oat Cell anonymous support group with info...
Tergum: Scutal margin prominently denticulated at lower margin; carinal margin protuberant in upper third to half and highly ridged; occasionally protuberant, separated from the rest of the valve by a narrow groove, growth ridges fine, strong and granulated near the lower scutal margin; sometimes very slight longitudinal striae on the carinal side; spur fasciole usually shallow and in level with the carinal and scutal surface of the tergum; sometimes, spur fasciole separated from scutal as well as carinal side by a narrow groove at the lower half; spur usually obliquely truncated in smaller specimens and almost rounded in older specimens; basal margin usually straight on both sides of spur; occasionally slightly concave on scutal side, rarely on carinal side ...
You must act fast to keep this type of aggressive tumor from growing: squamous-cell carcinoma requires a biopsy to confirm and must be handled aggressively or this cancer will destroy your cats life ...
Congenital lung diseases include bronchogenic cysts, congenital cystic adenomatoid malformations, lobar emphysema and pulmonary sequestrations, according to Childrens Health. Doctors diagnose about...
The CYP1A1 and CYP1B1 genes are members of aromatic hydrocarbon receptor battery genes. The expression of these genes, therefore, is thought to be induced concomitantly through the activation of aromatic hydrocarbon receptor. In agreement with this concept, both CYP1A1 and CYP1B1 mRNAs were induced by the treatment of human blood monocytes with dioxins or PAHs in vitro (11 , 12) . The subjects whose leukocytes were analyzed in this study were workers occupationally exposed to dioxins at waste incinerators (9) . Thus, we expected that both CYP1A1 and CYP1B1 mRNAs might be induced by environmental exposure to dioxins. However, we found that the expression of only CYP1B1 mRNA was induced, whereas the expression of CYP1A1 mRNA was not induced. The reason accounting for the fact that only CYP1B1 mRNA was induced is not known at present.. After the first report on the significant association between AHH inducibility in human lymphocytes and the bronchogenic cancer risk (3) , many papers have appeared ...
Cause Meaning * Bronchial Cancer * Bronchiectasis * Chronic Lung Disease * Emphysema * Lung Cancer * Lung Disease * Mesothelioma * Waldenstroms Macroglobulinemia
List of words make out of Pneumonectomies. All anagrams of Pneumonectomies. Words made after unscrambling Pneumonectomies. Scrabble Points. Puzzle Solver. Word Creation.
Conditions: Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms; Sarcoma; Colorectal Neoplasms; Salivary Gland Neoplasms; Biliary Tract Neoplasms; Brain Neoplasm, Primary; Carcinoma, Ductal, Breast; Melanoma; Solid Tumors; Glioblastoma; Bile Duct Neoplasms; Astrocytoma; Head and Neck Squamous Cell Carcinoma; Pontine Glioma; Pancreatic Neoplasms; Ovarian Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Carcinoma; Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms, Nerve Tissue; Nevi and ...
Congenital lung anomalies include primarily tracheobronchial atresia, bronchogenic cysts, pulmonary dysplasia, pulmonary sequestration, congenital cystic adenomatoid malformations, and congenital lobar emphysema.
Ovarian cysts and back pain can go hand in hand for women who are suffering from this condition. Diagnosis and treatment of ovarian cancer (OC) entail severe symptom burden and a significant loss of quality of life (QOL). Although pericardial celomic or mesothelial cysts are infrequent mediastinal lesions, they represent the most common benign mass lesion from the pericardium.. By getting to the underlying driver of the issue, the natural ovarian cyst cure without surgery Methods will keep the blisters from repeating., and numerous women possess relieved themselves of ovarian cysts forever using these holistic remedies. Case demonstration During a routine ultrasound examination of a Caucasian 25-year-old woman, a structure that raised our suspicions of an ovarian cyst was found.. In fact, the distinction between esophageal and bronchogenic cysts is not always clear. When it comes to womens cancers, ovarian cancer is the most serious of all the gynecological cancers - but the symptoms are vague, ...
5.1 Exposure data. Exposure to dimethyl sulfate may occur during its manufacture and its use as a methylating agent.. 5.2 Human carcinogenicity data. No epidemiological studies were available to the Working Group. A small number of cases of, mainly, bronchial carcinoma has been reported.. 5.3 Animal carcinogenicity data. Dimethyl sulfate was tested for carcinogenicity in rats by inhalation, subcutaneous and intravenous injection, and following prenatal exposure. It produced local sarcomas and tumours of the nervous system.. 5.4 Other relevant data. Dimethyl sulfate rapidly decomposes on contact with water, as a result of which it very rapidly disappears from the circulation of dosed rats.. It is corrosive or irritant to the skin, eyes and respiratory tract of exposed people, and may result in death caused by respiratory failure.. Dimethyl sulfate is embryotoxic to rats and causes malformations among surviving foetuses.. Workers exposed to dimethyl sulfate have developed chromosomal aberrations ...
Large cell carcinoma Accounts for 5-10% of all lung cancers. Strongly associated with cigarette smoking. The lesion occurs peripherally and grows rapidly, with early metastases and a poor outcome They lack any diagnosic features to suggest their diagnosis prior to biopsy.
The syndrome of inappropriate secretion of antidiuretic hormone is characterized by hyponatremia, decreased serum osmolality (less than 280 mosml/kg), increased urine osmolality (more than 150 mosm/kg), urinary sodium of more than 20 mg/L ...
We have previously demonstrated that vascular count significantly increases in the preneoplastic lesions of the bronchial tree, starting from very low levels in the normal epithelium to a significantly higher number of microvessels in moderate dysplastic lesions and in situ carcinomas. Vascular endothelial growth factor (VEGF) protein expression has shown to be strictly associated with neovascularization both in human cancer and in various type of preinvasive lesions. A number of studies have demonstrated that mutant p53 is involved in the regulation of angiogenesis, and immunohistochemical detection of the p53 protein is associated with p53 gene mutations. In this study we looked for possible correlation between p53 protein detection, VEGF expression and vascular count in a series of preneoplastic and neoplastic lesions of the bronchial tree in order to investigate the angiogenic pattern and its genetic control in the early steps of bronchial cancer development. Twenty-four retrospective ...
Dictionary.WM: A compact free online dictionary for daily uses. Search your words for accurate meanings, type, usage, images, and synonyms.
Small round malignant cells that grow rapidly and spread throughout the body. Almost all cases of small cell lung cancer is caused by smoking. Also known as Oat Cell cancer. There are three types of lung cancer: Small Cell (Oat Cell), mixed small cell/large cell carcinoma, and combined small cell carcinoma.
Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy ...
Small Cell Cancer (SCLC) is much more rare than Non-Small Cell, only about 15% of cases are Small Cell. Within SCLC, there are three different types: small cell carcinoma (oat cell cancer), mixed small cell/large cell carcinoma and combined small cell carcinoma. Most SCLC cases are oat cell. SCLC is the most aggressive form of lung cancer compared to the other type. It is mainly caused by smoking and starts in the bronchi (breathing tubes) in the center of the chest. This type of lung cancer grows quickly and produces large tumors. Because SCLC grows so quickly, it also metastasizes rapidly to other parts of the body including the brain, liver and bone. Metastasis is when a part of a cancerous tumor breaks off from the original tumor and spreads to another part of the body, spreading the cancer. When you have SCLC, there are many symptoms that come from it, including bloody sputum (spitting up blood), chest pain, coughing, loss of appetite, shortness of breath, weight loss, wheezing, facial ...
Small Cell Cancer (SCLC) is much more rare than Non-Small Cell, only about 15% of cases are Small Cell. Within SCLC, there are three different types: small cell carcinoma (oat cell cancer), mixed small cell/large cell carcinoma and combined small cell carcinoma. Most SCLC cases are oat cell. SCLC is the most aggressive form of lung cancer compared to the other type. It is mainly caused by smoking and starts in the bronchi (breathing tubes) in the center of the chest. This type of lung cancer grows quickly and produces large tumors. Because SCLC grows so quickly, it also metastasizes rapidly to other parts of the body including the brain, liver and bone. Metastasis is when a part of a cancerous tumor breaks off from the original tumor and spreads to another part of the body, spreading the cancer. When you have SCLC, there are many symptoms that come from it, including bloody sputum (spitting up blood), chest pain, coughing, loss of appetite, shortness of breath, weight loss, wheezing, facial ...
ERYtech is developing immunotherapies using red blood cells (RBCs) as a natural delivery system of tumour-associated antigen to antigen presenting cells (APCs),

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. | JEMInhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. | JEM

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.. D R Smith, P J Polverini, S L Kunkel, M B ... Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.. D R Smith, P J Polverini, S L Kunkel, M B ... Our observations definitively establish IL-8 as a primary mediator of angiogenesis in bronchogenic carcinoma and offer a ... We investigated the role of interleukin 8 (IL-8) in mediating angiogenesis in human bronchogenic carcinoma. Increased ...
more infohttp://jem.rupress.org/content/179/5/1409

A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis. | Postgraduate...A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis. | Postgraduate...

A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis. ... A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis. ... A patient is described with small cell carcinoma of the lung, associated with profound hypophosphataemia and hyponatraemia. ...
more infohttp://pmj.bmj.com/content/70/828/746

A retrospective study of thirty-two patients with small-cell bronchogenic carcinoma and inappropriate secretion of antidiuretic...A retrospective study of thirty-two patients with small-cell bronchogenic carcinoma and inappropriate secretion of antidiuretic...

Inadequate ADH-secretion associated with bronchogenic carcinoma (Schwartz-Bartter syndrome)]. * Authors: Dieckmann B, Achenbach ... A retrospective study of thirty-two patients with small-cell bronchogenic carcinoma and inappropriate secretion of antidiuretic ... A retrospective study of thirty-two patients with small-cell bronchogenic carcinoma and inappropriate secretion of antidiuretic ... Inappropriate secretion of antidiuretic hormone in nude mice bearing a human bronchogenic oat cell carcinoma. ...
more infohttps://christie.openrepository.com/handle/10541/108034

Enteric Adenocarcinoma Arising From a Bronchogenic Cyst | Archivos de BronconeumologíaEnteric Adenocarcinoma Arising From a Bronchogenic Cyst | Archivos de Bronconeumología

... histological findings were bronchioalveolar carcinoma, adenocarcinoma, squamous cell carcinoma and large cell carcinoma. To the ... but in all cases the carcinoma was found in the cyst wall. To the best of our knowledge, this is the first case of bronchogenic ... bronchogenic cysts were associated with malignancies: 1 squamous cell, 1 adenocarcinoma, 2 bronchioalveolar carcinomas and 1 ... Bronchogenic cysts are congenital lesions thought to originate from the primitive ventral foregut,2 and are the result of ...
more infohttp://archbronconeumol.org/es/enteric-adenocarcinoma-arising-from-bronchogenic/articulo/S0300289617300431/

Bronchogenic carcinoma | Define Bronchogenic carcinoma at Dictionary.comBronchogenic carcinoma | Define Bronchogenic carcinoma at Dictionary.com

Bronchogenic carcinoma definition at Dictionary.com, a free online dictionary with pronunciation, synonyms and translation. ... Squamous cell or oat cell carcinoma that develops in the mucosa of the large bronchi and produces a persistent productive cough ...
more infohttps://www.dictionary.com/browse/bronchogenic-carcinoma

Transbronchial Needle Aspiration in the Staging of Bronchogenic CarcinomaTransbronchial Needle Aspiration in the Staging of Bronchogenic Carcinoma

... Emil Benov, Krassimir Michev, Dimitar Kostadinov, ... we have prospectively examined 316 patients with morphologically verified bronchogenic carcinoma. The percentage of positive ... Metastases were proved in 14 of 39 patients with peripheral versus 135 of 277 patients with central carcinoma. Tumor cells were ... aspirated in 47 of 76 patients with undifferentiated small cell carcinoma, 92 of 227 patients with squamous cell carcinoma, and ...
more infohttps://www.hindawi.com/journals/dte/1996/237680/abs/

Definition of bronchogenic carcinoma - NCI Dictionary of Cancer Terms - National Cancer InstituteDefinition of bronchogenic carcinoma - NCI Dictionary of Cancer Terms - National Cancer Institute

bronchogenic carcinoma listen (BRON-koh-JEH-nik KAR-sih-NOH-muh) Cancer that begins in the tissue that lines or covers the ...
more infohttps://www.cancer.gov/publications/dictionaries/cancer-terms/def/bronchogenic-carcinoma

Bronchogenic carcinoma | definition of bronchogenic carcinoma by Medical dictionaryBronchogenic carcinoma | definition of bronchogenic carcinoma by Medical dictionary

What is bronchogenic carcinoma? Meaning of bronchogenic carcinoma medical term. What does bronchogenic carcinoma mean? ... Looking for online definition of bronchogenic carcinoma in the Medical Dictionary? bronchogenic carcinoma explanation free. ... Related to bronchogenic carcinoma: Bronchoalveolar Carcinoma. carcinoma. [kahr″sĭ-no´mah] (pl. carcinomas, carcino´mata) a ... carcinoma sim´plex an undifferentiated carcinoma.. small cell carcinoma a common, highly malignant form of bronchogenic ...
more infohttps://medical-dictionary.thefreedictionary.com/bronchogenic+carcinoma

Estrogen and Progesterone Receptors in Bronchogenic Carcinoma | Cancer ResearchEstrogen and Progesterone Receptors in Bronchogenic Carcinoma | Cancer Research

Estrogen and Progesterone Receptors in Bronchogenic Carcinoma. Philip T. Cagle, Dina R. Mody and Mary R. Schwartz ... Estrogen and Progesterone Receptors in Bronchogenic Carcinoma Message Subject (Your Name) has forwarded a page to you from ... Three squamous cell carcinomas were positive for ER (,6.9 fmol/mg cytosol protein). Three squamous cell carcinomas, two ... organs suggest that sex hormones may have a role in the pathogenesis of bronchogenic carcinoma. To confirm that estrogen (ER) ...
more infohttp://cancerres.aacrjournals.org/content/50/20/6632

Relation between bronchoscopic findings and tumor size of roentgenographically occult bronchogenic squamous cell carcinoma.  -...Relation between bronchoscopic findings and tumor size of roentgenographically occult bronchogenic squamous cell carcinoma. -...

A total of 105 lesions in 98 patients with roentgenographically occult bronchogenic squamous cell carcinoma were examined. The ... Relation between bronchoscopic findings and tumor size of roentgenographically occult bronchogenic squamous cell carcinoma.. ... findings into these three categories for the study of roentgenographically occult bronchogenic squamous cell carcinomas. ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/8246545?dopt=Abstract

Human Bronchogenic Carcinoma, sec. 7 µm H&E Microscope Slide | Carolina.comHuman Bronchogenic Carcinoma, sec. 7 µm H&E Microscope Slide | Carolina.com

Microscope slide of human lung infected with bronchogenic carcinoma, a lung cancer arising from the epithelium of the bronchus ... Human Bronchogenic Carcinoma, sec. 7 µm H&E Microscope Slide. Item # 317762 Online Only *bvseo_sdk, java_sdk, bvseo-4.0.0 ... Microscope slide of human lung infected with bronchogenic carcinoma, a lung cancer arising from the epithelium of the bronchus ... Microscope slide of human lung infected with bronchogenic carcinoma, a lung cancer arising from the epithelium of the bronchus ...
more infohttps://www.carolina.com/histology-microscope-slides/human-bronchogenic-carcinoma-sec-7-um-h-e-microscope-slide/317762.pr

CYFRA 21-1 as a tumour marker for bronchogenic carcinoma | European Respiratory SocietyCYFRA 21-1 as a tumour marker for bronchogenic carcinoma | European Respiratory Society

CYFRA 21-1 as a tumour marker for bronchogenic carcinoma. M Rapellino, J Niklinski, F Pecchio, M Furman, S Baldi, L Chyczewski ... CYFRA 21-1 as a tumour marker for bronchogenic carcinoma. M Rapellino, J Niklinski, F Pecchio, M Furman, S Baldi, L Chyczewski ... CYFRA 21-1 as a tumour marker for bronchogenic carcinoma. M Rapellino, J Niklinski, F Pecchio, M Furman, S Baldi, L Chyczewski ... CYFRA 21-1 as a tumour marker for bronchogenic carcinoma Message Subject (Your Name) has sent you a message from European ...
more infohttps://erj.ersjournals.com/content/8/3/407

Symposium on lung tumors; bronchogenic carcinoma | The Journal of the American Osteopathic AssociationSymposium on lung tumors; bronchogenic carcinoma | The Journal of the American Osteopathic Association

Symposium on lung tumors; bronchogenic carcinoma. The Journal of the American Osteopathic Association, August 1955, Vol. 54, ... Symposium on lung tumors; bronchogenic carcinoma You will receive an email whenever this article is corrected, updated, or ... REED A. Symposium on lung tumors; bronchogenic carcinoma. J Am Osteopath Assoc 1955;54(12):757-760. doi: https://doi.org/. ...
more infohttps://jaoa.org/article.aspx?articleid=2095282

A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkins...A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin's...

A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkins ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/13631504?dopt=Abstract

Empyema caused by Kingella denitrificans and Peptostreptococcus spp. in a patient with bronchogenic carcinoma | European...Empyema caused by Kingella denitrificans and Peptostreptococcus spp. in a patient with bronchogenic carcinoma | European...

in a patient with bronchogenic carcinoma. R Molina, T Baro, J Torne, R Miralles, J Gutierrez, JF Solsona, C Alia ... was diagnosed in a patient with bronchogenic carcinoma. This appears to be the third report providing evidence of a pathogenic ...
more infohttp://erj.ersjournals.com/content/1/9/870

Bronchogenic carcinoma with metastatic lymphadenopathy | Radiology Case | Radiopaedia.orgBronchogenic carcinoma with metastatic lymphadenopathy | Radiology Case | Radiopaedia.org

Right lung upper lobe apical segment bronchogenic cancer with pleural invasion as well as malignant mediastinal and right hilar ... Bronchogenic carcinoma with metastatic lymphadenopathy. Case contributed by Dr Mohammad A. ElBeialy ... Right lung upper lobe apical segment bronchogenic cancer with pleural invasion as well as malignant mediastinal and right hilar ...
more infohttps://radiopaedia.org/cases/bronchogenic-carcinoma-with-metastatic-lymphadenopathy

DEGENERATIVE VERRUCAL ENDOCARDIOSIS AND MYOCARDIAL INFARCTION: REPORT OF TWO CASES ASSOCIATED WITH MUCUS-PRODUCING BRONCHOGENIC...DEGENERATIVE VERRUCAL ENDOCARDIOSIS AND MYOCARDIAL INFARCTION: REPORT OF TWO CASES ASSOCIATED WITH MUCUS-PRODUCING BRONCHOGENIC...

REPORT OF TWO CASES ASSOCIATED WITH MUCUS-PRODUCING BRONCHOGENIC CARCINOMA* G. D. AMROMIN, M.D.; S. K. WANG, M.D. ... There are many examples which do not terminate a long-term illness, such as carcinoma, but which may be seen in more or ... REPORT OF TWO CASES ASSOCIATED WITH MUCUS-PRODUCING BRONCHOGENIC CARCINOMA*. Ann Intern Med. 1959;50:1519-1529. doi: https:// ...
more infohttps://annals.org/aim/article-abstract/677209/degenerative-verrucal-endocardiosis-myocardial-infarction-report-two-cases-associated-mucus

Adrenal-pituitary Studies in a Patient with Bronchogenic Carcinoma and Cushings Syndrome | Annals of Internal Medicine |...Adrenal-pituitary Studies in a Patient with Bronchogenic Carcinoma and Cushing's Syndrome | Annals of Internal Medicine |...

Adrenal-pituitary Studies in a Patient with Bronchogenic Carcinoma and Cushings Syndrome RICHARD A. PFOHL, M.D.; RICHARD P. ... Adrenal-pituitary Studies in a Patient with Bronchogenic Carcinoma and Cushings Syndrome. Ann Intern Med. 1963;58:993-1002. ... An increasing association has been noted between anaplastic carcinoma of the lung and Cushings syndrome. Elevated plasma and ...
more infohttps://annals.org/aim/article-abstract/678760/adrenal-pituitary-studies-patient-bronchogenic-carcinoma-cushing-s-syndrome

Lirias: Surgical treatment of bronchogenic carcinoma: a retrospective study of 720 thoracotomiesLirias: Surgical treatment of bronchogenic carcinoma: a retrospective study of 720 thoracotomies

Surgical treatment of bronchogenic carcinoma: a retrospective study of 720 thoracotomies. Authors: Deneffe, Georges ×. Lacquet ... Seven hundred and twenty patients with primary bronchogenic carcinoma were operated on at the Pellenberg Clinic, K.U. Leuven, ... Patients with squamous cell carcinoma (Stages I and II) who underwent lobectomy or pneumonectomy had an absolute 5-year ...
more infohttps://lirias.kuleuven.be/handle/123456789/29110

Clinical effect of two-ports thoracoscopic pulmonary lobectomy and systemic lymphadenectomy for bronchogenic carcinomaClinical effect of two-ports thoracoscopic pulmonary lobectomy and systemic lymphadenectomy for bronchogenic carcinoma

... , Shimeng ... Bronchogenic carcinoma, Lung cancer. Introduction. Bronchogenic carcinoma is a common clinical disease, which is also called ... of cancer patients throughout the world are bronchogenic carcinoma patients [1]. However, the cause of bronchogenic carcinoma ... At abroad, there were some experts who have used single-port VATS for curing bronchogenic carcinoma, which has made good ...
more infohttp://www.alliedacademies.org/articles/clinical-effect-of-twoports-thoracoscopic-pulmonary-lobectomy-and-systemic-lymphadenectomy-for-bronchogenic-carcinoma-8505.html

Editorials: elevated plasma calcitonin as a marker for bronchogenic carcinoma. - Semantic ScholarEditorials: elevated plasma calcitonin as a marker for bronchogenic carcinoma. - Semantic Scholar

These investigators found that 62 percent (16) of 26 patients with bronchogenic carcinoma had elevated plasma levels of ... in discovering early bronchogenic carcinoma and in drawing inferences as to the histologic type of the tumor. Serial calcitonin ... growth hormone in anaplastic carcinomas and adenocarcinomas, and parathyroid hormone predominantly in sauamous-cell carcinomas ... In 1974, Silva et a12 described two patients with ectopic secretion of calcitonin by oat-cell carcinomas of the lung. Several ...
more infohttps://www.semanticscholar.org/paper/Editorials%3A-elevated-plasma-calcitonin-as-a-marker-Williams/8cd5322fce8584feb85db87647b9d4a73415baa9

The bronchogenic carcinoma-laryngeal cancer association: the...The bronchogenic carcinoma-laryngeal cancer association: the...

The bronchogenic carcinoma-laryngeal cancer association: the experience of our school].: In a 20 year period (1974-1995), 3451 ... The bronchogenic carcinoma-laryngeal cancer association: the experience of our school].. Authors * Mascitelli, E ... In a 20 year period (1974-1995), 3451 patients with bronchogenic carcinoma were observed. Retrospective analysis of these cases ... In 32 patients synchronous or metachronous carcinoma of the larynx and lung were found. All laryngeal tumours were curable but ...
more infohttps://www.mysciencework.com/publication/show/bronchogenic-carcinoma-laryngeal-cancer-association-experience-our-school-8cc5c064

Bronchogenic Carcinoma (Bronchial Carcinomas): Symptoms, Diagnosis and Treatment - Symptoma®Bronchogenic Carcinoma (Bronchial Carcinomas): Symptoms, Diagnosis and Treatment - Symptoma®

Bronchogenic carcinoma is the leading cause of cancer death throughout the world and tobacco smoking is shown to be the single ... Bronchogenic Carcinoma. Bronchial Carcinomas. Bronchogenic carcinoma is the leading cause of cancer death throughout the world ... Bronchogenic carcinoma, one of the most common malignant diseases worldwide, is the leading cause of death from cancers in the ... Bronchogenic carcinoma (lung cancer) is the leading cause of death from a malignant disease worldwide, with more than 160,000 ...
more infohttps://www.symptoma.com/en/info/bronchogenic-carcinoma

The surgery of non-small-cell bronchogenic carcinoma in stage...The surgery of non-small-cell bronchogenic carcinoma in stage...

An analysis of 150 treated cases].: Surgery of bronchogenic carcinoma at stage IIIA has not ... The surgery of non-small-cell bronchogenic carcinoma in stage IIIA. ... The surgery of non-small-cell bronchogenic carcinoma in stage IIIA. An analysis of 150 treated cases].. Authors * Briccoli, A ... Surgery of bronchogenic carcinoma at stage IIIA has not obtained promising results in terms of survival. However, no other ...
more infohttps://www.mysciencework.com/publication/show/surgery-non-small-cell-bronchogenic-carcinoma-stage-iiia-analysis-150-treated-cases-585524cf

Bronchogenic Carcinoma Etiopathogenesis | EpomedicineBronchogenic Carcinoma Etiopathogenesis | Epomedicine

Bronchogenic Carcinoma Etiopathogenesis. Epomedicine Jul 2, 2016 No Comments Internal medicineRespiratory system. Last modified ... Non small cell carcinoma: mutations in EGFR, KRAS, CD44, and p16*Squamous cell (epidermoid) carcinoma ... Squamous dysplasia: Squamous cell carcinoma. Adenomatous hyperplasia: Bronchioalveolar carcinoma (BAC) - a form of ... which can cause all types of lung cancer but is more strongly linked with Small cell carcinoma and Squamous-cell carcinoma. ...
more infohttps://epomedicine.com/medical-students/bronchogenic-carcinoma-lung-cancer/
  • Like nearly all lung carcinomas, however, GCCs are exceedingly rare in very young people: in the US SEER program, only 2 cases were recorded to occur in persons younger than 30 years of age between 1983 and 1987. (wikipedia.org)
  • occupation : Industrial workers in the mining of radioactive ores, refining of nickel.manufacture of chromates and coal gas, and processing of arsenic and asbestos are liable to develop bronchogenic carcinoma. (tripod.com)
  • In our preliminary experience with selected patients suspected to have bronchogenic carcinoma (based on peribronchial disease or subcarinal lymphadenopathy), we found TBNA a safe and useful tool. (rcjournal.com)
  • Although the lung is not usually considered a major target organ of sex hormones, epidemiological observations, studies of pulmonary neoplasms in laboratory animals, and investigations of carcinomas derived from other "nontarget" organs suggest that sex hormones may have a role in the pathogenesis of bronchogenic carcinoma. (aacrjournals.org)
  • Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. (medscape.com)